XML 19 R7.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Shares
Additional Paid-in Capital
Treasury Shares
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Noncontrolling Interests
Beginning Balance at Dec. 31, 2023 $ 1,516,387 $ 142 $ 387,210 $ (10,261) $ 22,865 $ 882,943 $ 233,488
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 116,596         68,922 47,674
Other comprehensive loss 3,545       3,545    
Amounts reclassified from Accumulated other comprehensive income (11,034)       (11,034)    
Distributions to noncontrolling interests (87,325)           (87,325)
Stock awards issued to employees and directors, net of income tax (3,718)   5,909 (9,627)      
Dividends declared per common share (19,416)         (19,416)  
Stock award dividend equivalents 536   708 62   (234)  
Ending Balance at Sep. 30, 2024 1,523,007 142 382,009 (572) 15,376 932,215 193,837
Beginning Balance at Jun. 30, 2024 1,520,261 142 378,453 (631) 21,181 911,455 209,661
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 51,461         27,365 24,096
Other comprehensive loss (2,383)       (2,383)    
Amounts reclassified from Accumulated other comprehensive income (3,422)       (3,422)    
Distributions to noncontrolling interests (39,920)           (39,920)
Stock awards issued to employees and directors, net of income tax (3,614)   (3,556) (58)      
Dividends declared per common share (6,472)         (6,472)  
Stock award dividend equivalents (132)     1   (133)  
Ending Balance at Sep. 30, 2024 1,523,007 142 382,009 (572) 15,376 932,215 193,837
Beginning Balance at Dec. 31, 2024 1,599,836 142 385,609 (2,860) 12,585 970,710 233,650
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 48,209         28,279 19,930
Other comprehensive loss 3,571       3,571    
Amounts reclassified from Accumulated other comprehensive income (5,439)       (5,439)    
Distributions to noncontrolling interests (33,657)           (33,657)
Purchase of noncontrolling interest in a consolidated subsidiary (366,106)   (188,092)       (178,014)
Stock awards issued to employees and directors, net of income tax (11,748) (2) (7,652) (4,094)      
Purchase of treasury shares (15,366)     (15,366)      
Dividends declared per common share (19,935)         (19,935)  
Stock award dividend equivalents 156   492 1   (337)  
Ending Balance at Sep. 30, 2025 1,223,017 144 205,661 (14,131) 10,717 978,717 41,909
Beginning Balance at Jun. 30, 2025 1,610,510 144 384,654 0 14,334 965,277 246,101
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 26,071         20,138 5,933
Other comprehensive loss (2,757)       (2,757)    
Amounts reclassified from Accumulated other comprehensive income (860)       (860)    
Distributions to noncontrolling interests (32,111)           (32,111)
Purchase of noncontrolling interest in a consolidated subsidiary (366,106)   (188,092)       (178,014)
Stock awards issued to employees and directors, net of income tax (9,141)   (9,090) 51      
Purchase of treasury shares (14,182)     (14,182)      
Dividends declared per common share (6,598)         (6,598)  
Stock award dividend equivalents (91)   9     (100)  
Ending Balance at Sep. 30, 2025 $ 1,223,017 $ 144 $ 205,661 $ (14,131) $ 10,717 $ 978,717 $ 41,909